Trademark Overview
On Friday, May 10, 2024, a trademark application was filed for IBDIQ with the United States Patent and Trademark Office. The USPTO has given the IBDIQ trademark a serial number of 98544929. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, May 10, 2024. This trademark is owned by Takeda Pharmaceuticals International AG. The IBDIQ trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Healthcare provider and medical professional support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve the understanding of healthcare providers and medical professionals about Inflammatory Bowel Disease (IBD) and pharmaceutical treatment thereof.